文献速递外周动脉疾病

GLASS踝下修饰因子对远端旁路术后CLTI长期结局的影响

Does the Global Limb Anatomic Staging System Inframalleolar Modifier Influence Long Term Outcomes of Chronic Limb Threatening Ischaemia after Distal Bypass?
PubMed 文献 · Eur J Vasc Endovasc Surg · 2021-08-28

单中心回顾性研究纳入206例患者共254条远端旁路,按GLASS IM修饰因子分为P0、P1、P2三组。三组3年保肢率无显著差异,但P2组3年一期通畅率和12个月创面愈合率显著低于P0组。

要点

  • GLASS IM修饰因子P2与远端旁路术后一期通畅率降低显著相关。
  • P2组12个月创面愈合率显著低于P0和P1组。
  • 各GLASS IM修饰因子组3年保肢率无显著差异。

核心结论

  • 对于膝下病变的CLTI患者,各GLASS IM修饰因子组的远端旁路术后长期通畅、保肢和创面愈合结局均可接受。

研究设计与样本

  • 单中心回顾性研究,2012年1月至2019年12月共206例患者(139例男性,中位年龄76岁)接受254条远端旁路。

主要发现

  • GLASS IM修饰因子分布为P0 80条(32%)、P1 127条(50%)、P2 47条(18%)。
  • 随访期间22条肢体(9%)需大截肢,P0、P1、P2组3年保肢率分别为94%、89%、93%,组间无显著差异。
  • P0、P1、P2组3年一期通畅率分别为49%、38%、24%,P2组显著低于P0组(p < .050)。
  • P0、P1、P2组12个月创面愈合率分别为97%、93%、79%,P2组显著低于其他组(p < .050)。

临床怎么用

  • 远端旁路术前评估GLASS IM修饰因子有助于预判通畅率和创面愈合风险。
  • P2患者术后应加强 graft 监测和创面管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The purpose of this study was to evaluate the influence of inframalleolar disease (Global Limb Anatomic Staging System Inframalleolar [GLASS IM] modifier) on long term outcomes of patients with chronic limb threatening ischaemia (CLTI) after distal bypass. METHODS: Patients who underwent distal bypass for CLTI from January 2012 to December 2019 at a single centre were reviewed retrospectively. Comparisons including baseline characteristics, procedural details, and long term outcomes were made between patients with an intact pedal arch (GLASS IM modifier P0), an absent or severely diseased pedal arch (P1), and no target artery crossing the ankle into the foot (P2), diagnosed by pre- and intra-operative high quality angiography. The primary endpoint was limb salvage. The secondary endpoints were graft patency and wound healing. RESULTS: A total of 254 distal bypasses were performed in 206 patients (139 males; median age, 76 years). The GLASS IM modifier was P0 in 80 (32%) limbs, P1 in 127 (50%), and P2 in 47 (18%). During the follow up period, 22 limbs (9%) required major amputation. The limb salvage rates at three years in P0, P1, and P2 cases were 94%, 89%, and 93%, respectively, with no significant differences among the modifiers. The primary patencies at three years in P0, P1, and P2 cases were 49%, 38% and 24%, respectively. The primary patency in P2 cases was significantly lower than that in P0 cases (p < .050). The respective wound healing rates at 12 months were 97%, 93%, and 79%, and again the wound healing rate in P2 cases was significantly lower than those in other cases (p < .050). CONCLUSION: Long term outcomes including patency, limb salvage, and wound healing after distal bypass for CLTI patients with an infrapopliteal lesion were acceptable in cases in each GLASS IM modifier.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. Kobayashi T, Hamamoto M, Okazaki T, et al. Does the Global Limb Anatomic Staging System Inframalleolar Modifier Influence Long Term Outcomes of Chronic Limb Threatening Ischaemia after Distal Bypass? Eur J Vasc Endovasc Surg. 2021. PMID: 34465536. doi:10.1016/j.ejvs.2021.07.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。